Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free NVOS Stock Alerts

Novo Integrated Sciences (NVOS) Competitors

$0.0023 0.00 (0.00%)
As of 08/14/2026
Compare

NVOS vs. IMAC, BACK, AONCW, BTSGU, and WGSWW

Should you buy Novo Integrated Sciences stock or one of its competitors? Novo Integrated Sciences's main competitors and comparable companies include IMAC (IMAC), IMAC (BACK), American Oncology Network (AONCW), BrightSpring Health Services (BTSGU), and GeneDx (WGSWW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Novo Integrated Sciences compare to IMAC?

IMAC (NASDAQ:IMAC) and Novo Integrated Sciences (NASDAQ:NVOS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

IMAC has a beta of -0.88, suggesting that its stock price is 188% less volatile than the broader market. Comparatively, Novo Integrated Sciences has a beta of 5.88, suggesting that its stock price is 488% more volatile than the broader market.

IMAC has a net margin of -75.40% compared to Novo Integrated Sciences' net margin of -121.55%. IMAC's return on equity of -52.17% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
IMAC-75.40% -52.17% -34.51%
Novo Integrated Sciences -121.55%-93.07%-46.28%

In the previous week, IMAC had 4 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 4 mentions for IMAC and 0 mentions for Novo Integrated Sciences. IMAC's average media sentiment score of 0.08 beat Novo Integrated Sciences' score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company Overall Sentiment
IMAC Neutral
Novo Integrated Sciences Neutral

24.3% of IMAC shares are owned by institutional investors. Comparatively, 5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.0% of IMAC shares are owned by company insiders. Comparatively, 10.4% of Novo Integrated Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

IMAC has higher revenue and earnings than Novo Integrated Sciences. Novo Integrated Sciences is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$15.22M0.00-$10.54M-$0.27N/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

Summary

IMAC beats Novo Integrated Sciences on 10 of the 13 factors compared between the two stocks.

How does Novo Integrated Sciences compare to IMAC?

IMAC (NASDAQ:BACK) and Novo Integrated Sciences (NASDAQ:NVOS) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

IMAC has higher earnings, but lower revenue than Novo Integrated Sciences. Novo Integrated Sciences is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K0.03-$9.42M-$3.12N/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

In the previous week, IMAC had 7 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 7 mentions for IMAC and 0 mentions for Novo Integrated Sciences. IMAC's average media sentiment score of 0.34 beat Novo Integrated Sciences' score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company Overall Sentiment
IMAC Neutral
Novo Integrated Sciences Neutral

IMAC has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. IMAC's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
Novo Integrated Sciences -121.55%-93.07%-46.28%

5.8% of IMAC shares are held by institutional investors. Comparatively, 5.7% of Novo Integrated Sciences shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Comparatively, 10.4% of Novo Integrated Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IMAC has a beta of 1.78, indicating that its stock price is 78% more volatile than the broader market. Comparatively, Novo Integrated Sciences has a beta of 5.88, indicating that its stock price is 488% more volatile than the broader market.

Summary

IMAC beats Novo Integrated Sciences on 9 of the 13 factors compared between the two stocks.

How does Novo Integrated Sciences compare to American Oncology Network?

American Oncology Network (NASDAQ:AONCW) and Novo Integrated Sciences (NASDAQ:NVOS) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

In the previous week, American Oncology Network's average media sentiment score of 0.00 equaled Novo Integrated Sciences'average media sentiment score.

Company Overall Sentiment
American Oncology Network Neutral
Novo Integrated Sciences Neutral

American Oncology Network has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. American Oncology Network's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
Novo Integrated Sciences -121.55%-93.07%-46.28%

American Oncology Network has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

American Oncology Network beats Novo Integrated Sciences on 4 of the 6 factors compared between the two stocks.

How does Novo Integrated Sciences compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSGU) and Novo Integrated Sciences (NASDAQ:NVOS) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, BrightSpring Health Services had 2 more articles in the media than Novo Integrated Sciences. MarketBeat recorded 2 mentions for BrightSpring Health Services and 0 mentions for Novo Integrated Sciences. BrightSpring Health Services' average media sentiment score of 1.43 beat Novo Integrated Sciences' score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Overall Sentiment
BrightSpring Health Services Positive
Novo Integrated Sciences Neutral

BrightSpring Health Services has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$14.37BN/AN/AN/AN/A
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A

BrightSpring Health Services has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. BrightSpring Health Services' return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
Novo Integrated Sciences -121.55%-93.07%-46.28%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Novo Integrated Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

5.7% of Novo Integrated Sciences shares are owned by institutional investors. 10.4% of Novo Integrated Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats Novo Integrated Sciences on 7 of the 9 factors compared between the two stocks.

How does Novo Integrated Sciences compare to GeneDx?

Novo Integrated Sciences (NASDAQ:NVOS) and GeneDx (NASDAQ:WGSWW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

GeneDx has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.52M0.00-$16.17M-$0.87N/A
GeneDx$442.68MN/AN/AN/AN/A

In the previous week, Novo Integrated Sciences' average media sentiment score of 0.00 equaled GeneDx'saverage media sentiment score.

Company Overall Sentiment
Novo Integrated Sciences Neutral
GeneDx Neutral

GeneDx has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. GeneDx's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
GeneDx N/A N/A N/A

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

GeneDx beats Novo Integrated Sciences on 4 of the 6 factors compared between the two stocks.

Get Novo Integrated Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVOS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVOS vs. The Competition

Export
MetricNovo Integrated SciencesHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$44K$9.75B$7.00B$13.02B
Dividend YieldN/A2.55%2.57%10.42%
P/E Ratio0.0034.75271.4125.46
Price / Sales0.004.83604.1798.16
Price / CashN/A24.8128.8738.47
Price / Book0.005.2311.096.52
Net Income-$16.17M$311.06M$3.45B$347.22M
7 Day PerformanceN/A-0.10%0.82%1.62%
1 Month PerformanceN/A-0.32%2.22%2.85%
1 Year PerformanceN/A18.83%63.12%21.23%

Novo Integrated Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVOS
Novo Integrated Sciences
N/A$0.00
flat		N/A+650.0%$44K$13.52MN/A170
IMAC
IMAC
N/A$0.00
+25.0%		N/A-99.3%$13K$15.22MN/A106
BACK
IMAC
N/A$0.00
flat		N/A-99.3%$2K$72.05KN/A180
AONCW
American Oncology Network
N/A$0.00
flat		N/AN/A$0.00$1.34BN/A1,525
BTSGU
BrightSpring Health Services
N/A$199.01
+0.5%		N/A+160.0%$0.00$14.37BN/A35,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NVOS) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel